“…On the other hand, synthetic mono- and dinuclear iron active site analogues serve as potential synthetic oxidation catalysts, and their properties have been widely explored also in this respect. Promising examples of mononuclear catalysts capable of alkane hydroxylation, olefin epoxidation, and cis -dihydroxylation have been reported. ,,,− Ligand systems that are widely used for the construction of both mono- and dinuclear iron complexes include the polydentate tris(2-pyridylmethyl)amine (tpa) and N , N ′-bis(2-pyridylmethyl)- N , N ′-dimethyl-1,2-ethylenediamine ligand family (bpmen) , and the N , N -bis(2-pyridylmethyl)- N -bis(2-pyridyl)methylamine (N4py), , 2-(2′,5′-diazapentyl)-5-bromopyrimidine-6-carboxylic acid N-[2,(4′-imidazolyl)ethyl]amide (Hpma), and tris((1-methylimidazol-2-yl)methyl)amine (tmima) ligands, among many others (Figure ). Efficient dinuclear iron oxidation catalysts were also reported, some of which with very simple bidentate ligands such as bipyridine (bipy) and phenanthroline (phen). ,, …”